Aditxt, Inc.
ADTX- Exchange
- OTC
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001726711
No open-market purchases or sales by Aditxt, Inc. insiders were filed in the last 90 days; 1 institution reported holding it in 13F filings for Q2 2026, worth $0 in total; no superinvestor holds it.
13F holders, Q3 2025
Institutional positions in Aditxt, Inc. as of Sep 30, 2025. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 14
- +1 vs. Q2 2025
- Shares held
- 48.0K
- +8.64K (+22.0%) vs. Q2 2025
- Total value
- $35.9K
- −$14.6K (−29.0%) vs. Q2 2025
- New holders
- 4
- 2 more added
- Sold out
- 3
- 5 more reduced
Compare with Q2 2025: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting ADTX on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 1 | $0 |
| Q1 2026 | 9 | $19.8K |
| Q4 2025 | 14 | $48.4K |
| Q3 2025 | 14 | $35.9K |
| Q2 2025 | 13 | $50.5K |
| Q1 2025 | 9 | $213.3K |
| Q4 2024 | 11 | $13.9K |
| Q3 2024 | 13 | $29.7K |
| Q2 2024 | 8 | $23.4K |
| Q1 2024 | 10 | $62.2K |
| Q4 2023 | 11 | $31.2K |
| Q3 2023 | 12 | $826.4K |
| Q2 2023 | 14 | $313.8K |
| Q1 2023 | 15 | $618.3K |
| Q4 2022 | 16 | $805.6K |
| Q3 2022 | 16 | $983.2K |
| Q2 2022 | 28 | $392.5K |
| Q1 2022 | 23 | $1.14M |
| Q4 2021 | 27 | $2.01M |
| Q3 2021 | 25 | $2.48M |
| Q2 2021 | 18 | $1.62M |
| Q1 2021 | 22 | $1.63M |
Institutions, Q3 2025
Shares, value and share of portfolio for each institution holding Aditxt, Inc.; share changes are against Q2 2025.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Virtu Financial LLC | 16,225 | $12.0K | 0.00% | −4,552−21.9% | Reduced |
| Geode Capital Management, LLC | 14,350 | $10.8K | 0.00% | +14,350 | New |
| Two Sigma Securities, LLC | 10,982 | $8.26K | 0.00% | +10,982 | New |
| Tower Research Capital LLC (TRC) | 4,517 | $3.40K | 0.00% | +490+12.2% | Added |
| Citigroup Inc | 1,645 | $1.24K | 0.00% | +1,645 | New |
| UBS Group AG | 134 | $101 | 0.00% | 00.0% | Unchanged |
| SBI Securities Co., Ltd. | 87 | $65 | 0.00% | −4−4.4% | Reduced |
| Bank of America Corp | 41 | $31 | 0.00% | +21+105.0% | Added |
| Group One Trading, L.P. | 2 | $2 | 0.00% | 00.0% | Unchanged |
| Advisor Group Holdings, Inc. | 2 | $2 | 0.00% | −1−33.3% | Reduced |
| Morgan Stanley | 1 | $1 | 0.00% | −700−99.9% | Reduced |
| IFP Advisors, Inc | 1 | $1 | 0.00% | −40−97.6% | Reduced |
| TD Waterhouse Canada Inc. | 1 | $1 | 0.00% | +1 | New |
| Darwin Advisors, LLC | 1 | $0 | 0.00% | 00.0% | Unchanged |
| HRT Financial LP | 0 | $0 | 0.00% | −13,459−100.0% | Sold out |
| Raymond James Financial Inc | 0 | $0 | 0.00% | −89−100.0% | Sold out |
| Jones Financial Companies LLLP | 0 | $0 | 0.00% | −1−100.0% | Sold out |